What the business is, and whether it's a good one at a fair price.
Operates hospitals providing kidney care and super-speciality medical services, and has expanded rapidly through acquisitions of multiple hospital and pathology businesses across India. Recently listed on BSE and NSE in December 2025, the company is now extending overseas with a board-approved plan to acquire 51 percent of Blue Tree Clinics LLC, a Dubai polyclinic offering plastic surgery, cosmetic, dental and chiropractic services. The Dubai target reported FY25 revenue of 10.54 million AED and net profit of 3.14 million AED. Subsidiaries brought in include Raj Pathology, Gujarat Surgical Hospital, Surya Hospital, Harmony Medicare, Parekh's Hospital and Patel Multispeciality Hospital, taking the group to a multi-hospital chain. Employee costs of 16.6 percent of revenue and other operating expenses of 39.4 percent are the largest cost lines.
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from GUJARAT KIDNEY N SUP SP L's filed financials and exchange disclosures
GUJARAT KIDNEY N SUP SP L is a Healthcare Services company listed on NSE and BSE, trading under the symbol GKSL.
Yes. Over the trailing twelve months GUJARAT KIDNEY N SUP SP L reported a net profit of ₹22 Cr on revenue of ₹116 Cr.
Not in the latest reported year — GUJARAT KIDNEY N SUP SP L's dividend payout for FY26 was nil.
No. Debt stands at 0.06× equity, and it carries net debt of ₹2 Cr. That is lower than 78% of its 24 Hospital peers.
On trailing P/E, GUJARAT KIDNEY N SUP SP L ranks 18 of 30 in Hospital — cheaper than 41% of them, against an industry median of 47.3×. This is a position, not a valuation judgement.
On a typical session GUJARAT KIDNEY N SUP SP L moves 1.02% — that is the median absolute close-to-close move across its last 173 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by GUJARAT KIDNEY N SUP SP L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
